$WOLV Cyber Crime ~ There's an App for That™ Ladies &

New Post Public Reply Private Reply Replies (0) Message Board
Lets Roll
$WOLV Cyber Crime ~ There's an App for That™
Ladies & Gentlemen
Cyber-crime is growing rapidly and is now crippling business and personal
identities on a daily basis. Today there are already in excess of 4 billion
mobile devices all running on Mobile Applications (software). Be they
from Apple, Google Android, BlackBerry or a host of others, they all have
an inherent flaw: none can protect or secure the device they run on from
hacking or intrusion with 100% certainty. (There are countless stories on the news web)

Security on computer equipment is now at a level of crisis; as was stated
by the US Government it is the single greatest threat to American
sovereignty - outweighing the War on Terrorism.

"How is this possible?"

The full answer is very complex as it is the same cause that has our
corporate and government computers the victims of billions of dollars in
losses from Cyber-crime and intrusion, fraud and intellectual property
theft. The short answer is that a software "App" must be watched at every
step as it internally processes data in order to keep it safe.

Thousands of companies have created technologies to watch data as it goes
"into" and "out of" the software, looking for anomalous or erroneous
activity that may have occurred. However none can watch the bit-by-bit
processing "inside" as the software is operating. No software can "watch
itself" to ensure the work it is doing is correct or authorized. There-in
lies the entire Cyber Security problem.

ENIGMAMobil™ has changed that paradigm and is creating ~ an app for that.

Within the first three pages of the easy read Investment document attached, you will
discover why the problem has never been solved before and what has now been
invented to solve this global crisis now.

What you are looking at here is a very rare world monopoly in one of the
largest revenue markets: Technology.

"Why doesn't someone else come up with the solution in the meantime?"

Quick Answer: The problem has been systemic for 45 years with no solution
and with the cyber crisis worsening every day, no one sees a short term
resolve. In fact, an $18 Billion contract was just pulled from one of the
largest security developers, CDC (for the Federal Government), by Congress
after 3 years into an attempt to solve the problem, citing the company had
made no acceptable progress toward a solution.

Even though the solution technology is fully patent protected (20yr), we do
not rest alone on that. ENIGMAMobil™ will be in the market 10 months
after this financing. Should another company attempt to create similar
software, they would not only be up against the patent, but the
game-changing language "Vulcan™( the patent name )", as discussed here-in, took a further 10
years of focused development to create. This "Vulcan™" language is
available exclusively to ENIGMAMobil™.

First to market solving a $2 Trillion dollar crisis has a clear "rite
of passage" for success. Patent aside again, the problem will have been
solved by ENIGMA, a new standard will have been set for security and the
spoils go to the victor.

To further enhance the investment the company has been structured with a
clear exit strategy in mind which is clearly defined inside the document.

This is a one-time opportunity for investment with no watering down to
follow. This is not so much about finding investors to risk - it is about
investors that are clear and informed on the problem and want to realize a
large gain for their knowledge of the magnitude of the problem.

I intend to have this financing closed in the short term. The market is
demanding a solution - the technology is ready.

Warm wishes,

David Chalk

(Dr.) David Chalk, d.Tech.
David Chalk Inc.
david@davidchalkinc.com

http://enigmamobile.com/

"You never change things by fighting the existing reality.
To change something, build a new model that makes the existing model
obsolete."
-- Richard Buckminster Fuller
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 35

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 85

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 189

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading

Top 5 Most Recently Viewed Articles

NVIDIA and Synopsys Forge Alliance to Transform Engineering

Updated Category News Views 137

Strategic Collaboration Between NVIDIA and Synopsys In an exciting development for the engineering and design industries, NVIDIA and Synopsys have joined forces in a strategic partnership that promises to revolutionize how these sectors operate. This collaboration aims to leverage NVIDIA's powerful computational capabilities alongside Synopsys' sophisticated engineering...

Continue Reading
EHang's Groundbreaking Pilotless Flight Marks a Historic Event

Updated Category News Views 110

EHang's Historic Pilotless Flight in Africa EHang Holdings Limited (Nasdaq: EH), a frontrunner in Urban Air Mobility (UAM), has made headlines by achieving a remarkable milestone: the first pilotless human-carrying flight of its EH216-S eVTOL aircraft in Africa. This significant event unfolded at the 9th Aviation Africa Summit in Kigali, marking a historic moment for the...

Continue Reading
Bang & Olufsen's Share Buyback: Strategic Moves for Growth

Updated Category News Views 112

Understanding Bang & Olufsen's Share Buyback Program Bang & Olufsen A/S has embarked on a significant initiative aimed at bolstering its long-term growth through its recent share buyback program. This strategic move is designed to hedge the company’s share-based long-term incentive programmes, showcasing their commitment to enhancing shareholder value. This article...

Continue Reading
Johnson & Johnson's Q2 Expectations and Analyst Ratings Insights

Updated Category News Views 275

Upcoming Earnings Announcement for Johnson & Johnson Johnson & Johnson (NYSE: JNJ) is preparing to disclose its earnings results for the upcoming second quarter. Analysts are closely watching the anticipated report, which is expected to provide valuable insights into the company's financial health. Expected Financial Performance Analyst forecasts suggest that Johnson &...

Continue Reading
Safe House Project Expands Impact with ATI Acquisition

Updated Category News Views 307

Safe House Project Expands Impact with ATI Acquisition This Giving Tuesday, the Safe House Project (SHP) shared exciting news about its acquisition of Anti-Trafficking International (ATI), an organization that has been pivotal in the fight against human trafficking. By incorporating ATI's respected practices and its renowned Just Ask Prevention Curriculum, SHP aims to...

Continue Reading